Variable | Entire Cohort (n = 104) | 1-year survivors* (n = 74) | 1-year non-survivors* (n = 24) | P value |
---|---|---|---|---|
Age in years, median (25th, 75th) | 63 (51, 72) | 60 (44, 70) | 69 (56, 77) | 0.026 |
Male, n (%) | 57 (55) | 38 (51) | 15 (63) | 0.36 |
Race, n (%) | Â | Â | Â | 0.19 |
 Caucasian (White) | 96 (92) | 67 (91) | 24 (100) |  |
 African American | 8 (8) | 7 (10) | 0 (0) |  |
 Statin use, n (%) | 33 (32) | 22 (30) | 8 (33) | 0.76 |
 Charlson Comorbidity Index, median (25th, 75th) | 3 (1, 4) | 2 (0, 4) | 4 (3, 5) | 0.002 |
Comorbidities, n (%) | ||||
 Solid cancer | 13 (13) | 8 (11) | 4 (17) | 0.48 |
 Hematologic cancer | 0 (0) | 0 (0) | 0 (0) | N/A |
 Dementia | 4 (4) | 4 (5.4) | 0 (0) | 0.57 |
 Heart failure | 9 (9) | 7 (10) | 2 (8) | 1 |
 Liver disease | 2 (2) | 2 (3) | 0 (0) | 1 |
 Chronic lung disease | 15 (14) | 11 (15) | 4 (17) | 1 |
 Chronic renal disease | 14 (13) | 9 (12) | 4 (17) | 0.73 |
 Prior stroke | 11 (11) | 7 (10) | 3 (13) | 0.70 |
 Coronary disease | 27 (26) | 17 (23) | 9 (38) | 0.19 |
 Diabetes | 37 (36) | 27 (37) | 9 (38) | 1 |
 Substance abuse | 4 (6) | 4 (5) | 0 (0) | 0.57 |
 Hypertension | 70 (67) | 49 (66) | 16 (67) | 1 |
 Atrial fibrillation | 15 (14) | 9 (12) | 4 (17) | 0.73 |
 Morbid obesity | 21 (20) | 16 (22) | 4 (17) | 0.77 |
 Peripheral artery disease | 7 (7) | 4 (5) | 3 (13) | 0.36 |
Reason for hospital admission, n (%) | Â | Â | Â | 0.60 |
 Planned surgery | 20 (19) | 15 (20) | 4 (17) |  |
 Trauma | 11 (11) | 10 (14) | 1 (4) |  |
 Active infection | 62 (60) | 42 (57) | 16 (67) |  |
 Non-infectious/chronic problems | 11 (11) | 7 (10) | 3 (13) |  |
 Inter-facility transfer, n (%) | 43 (41) | 28 (38) | 12 (50) | 0.34 |